Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma
Open Access
- 16 March 2020
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 14 (5) , 917-932
Abstract
Mast cells are a major component of the immune microenvironment in tumour tissues and modulate tumour progression by releasing pro‐tumorigenic and antitumorigenic molecules. Regarding the impact of mast cells on the outcomes of patients with lung adenocarcinoma (LUAD) patient, several published studies have shown contradictory results. Here, we aimed at elucidating the role of mast cells in early‐stage LUAD. We found that high mast cell abundance was correlated with prolonged survival in early‐stage LUAD patients. The mast cell‐related gene signature and gene mutation data sets were used to stratify early‐stage LUAD patients into two molecular subtypes (subtype 1 and subtype 2). The neural network‐based framework constructed with the mast cell‐related signature showed high accuracy in predicting response to immunotherapy. Importantly, the prognostic mast cell‐related signature predicted the survival probability and the potential relationship between TP53 mutation, c‐MYC activation and mast cell activities. The meta‐analysis confirmed the prognostic value of the mast cell‐related gene signature. In summary, this study might improve our understanding of the role of mast cells in early‐stage LUAD and aid in the development of immunotherapy and personalized treatments for early‐stage LUAD patients.Keywords
Funding Information
- China Scholarship Council (201608210186, 201708120056, 201708320347)
This publication has 48 references indexed in Scilit:
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- The critical role of mast cell‐derived hypoxia‐inducible factor‐1α in human and mice melanoma growthInternational Journal of Cancer, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- TP53 Mutations in Nonsmall Cell Lung CancerBioMed Research International, 2011
- Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cellsNature Medicine, 2010
- Angiogenesis and lymphangiogenesis in bronchial asthmaAllergy, 2010
- IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skinProceedings of the National Academy of Sciences, 2010
- Tryptase Mast Cells in Malignant Pleural Mesothelioma as an Independent Favorable Prognostic FactorJournal of Thoracic Oncology, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Mast cells are an essential hematopoietic component for polyp developmentProceedings of the National Academy of Sciences, 2007